A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial
Trial details
- Registry ID
- NCT04685993
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as testosterone undecanoate
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 TrialNCT04685993 | LPCN | Phase 2 | Completed | 2022-03-01Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |